APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oncology Adjuvants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oncology Adjuvants Industry Growth and Trends Forecast to 2032

Report ID 174018880119 December 2025116 pages

Choose your research edition.

Industry ResearchOncology Adjuvants Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Adjuvants Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Oncology Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Adjuvants Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Adjuvants Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oncology Adjuvants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oncology Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oncology Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology Adjuvants include Zhendong Pharmaceutical, Yibai Pharmaceutical, Main Luck Pharmaceuticals, SL Pharmaceutical, Sanofi, Livzon Pharmaceutical, Eli Lilly, Pfizer and Sanjiu Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oncology Adjuvants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncology Adjuvants market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology Adjuvants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology Adjuvants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oncology Adjuvants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncology Adjuvants Market by Company

Zhendong Pharmaceutical

Yibai Pharmaceutical

Main Luck Pharmaceuticals

SL Pharmaceutical

Sanofi

Livzon Pharmaceutical

Eli Lilly

Pfizer

Sanjiu Medical

Hengrui Medicine

Hisun Pharmaceutical

Biogen

Amgen

AstraZeneca

BMS

Oncology Adjuvants Segment by Type

Immunotherapy

Hormone therapy

Chemotherapy

Radiotherapy

Targeted therapy

Oncology Adjuvants Segment by Application

Cancer Research Institutes

Cancer Hospitals

Oncology Adjuvants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oncology Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immunotherapy Table 2. Major Company of Hormone therapy Table 3. Major Company of Chemotherapy Table 4. Major Company of Radiotherapy Table 5. Major Company of Targeted therapy Table 6. Global Oncology Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Oncology Adjuvants Sales by Type (2021-2026) & (K Units) Table 8. Global Oncology Adjuvants Sales Market Share in Volume by Type (2021-2026) Table 9. Global Oncology Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 10. Global Oncology Adjuvants Sales Market Share in Value by Type (2021-2026) Table 11. Global Oncology Adjuvants Price by Type (2021-2026) & (US$/Unit) Table 12. Global Oncology Adjuvants Sales by Type (2027-2032) & (K Units) Table 13. Global Oncology Adjuvants Sales Market Share in Volume by Type (2027-2032) Table 14. Global Oncology Adjuvants Sales by Type (2027-2032) & (US$ Million) Table 15. Global Oncology Adjuvants Sales Market Share in Value by Type (2027-2032) Table 16. Global Oncology Adjuvants Price by Type (2027-2032) & (US$/Unit) Table 17. North America Oncology Adjuvants Sales by Type (2021-2026) & (K Units) Table 18. North America Oncology Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Oncology Adjuvants Sales by Type (2021-2026) & (K Units) Table 20. Europe Oncology Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Oncology Adjuvants Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Oncology Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Oncology Adjuvants Sales by Type (2021-2026) & (K Units) Table 24. Latin America Oncology Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Oncology Adjuvants Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Oncology Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 27. Oncology Adjuvants Industry Trends Table 28. Oncology Adjuvants Industry Drivers Table 29. Oncology Adjuvants Industry Opportunities and Challenges Table 30. Oncology Adjuvants Industry Restraints Table 31. Global Oncology Adjuvants Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Oncology Adjuvants Revenue Market Share by Company (2021-2026) Table 33. Global Oncology Adjuvants Sales by Company (2021-2026) & (K Units) Table 34. Global Oncology Adjuvants Sales Share by Company (2021-2026) Table 35. Global Oncology Adjuvants Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Oncology Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Oncology Adjuvants Major Company Production Sites and Headquarters Table 38. Global Oncology Adjuvants Company, Product Type & Application Table 39. Global Oncology Adjuvants Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Oncology Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Oncology Adjuvants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Oncology Adjuvants Sales by Region (2021-2026) & (K Units) Table 44. Global Oncology Adjuvants Sales Market Share in Volume by Region (2021-2026) Table 45. Global Oncology Adjuvants Sales by Region (2021-2026) & (US$ Million) Table 46. Global Oncology Adjuvants Sales Market Share in Value by Region (2021-2026) Table 47. Global Oncology Adjuvants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Oncology Adjuvants Sales by Region (2027-2032) & (K Units) Table 49. Global Oncology Adjuvants Sales Market Share in Volume by Region (2027-2032) Table 50. Global Oncology Adjuvants Sales by Region (2027-2032) & (US$ Million) Table 51. Global Oncology Adjuvants Sales Market Share in Value by Region (2027-2032) Table 52. Global Oncology Adjuvants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Oncology Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Oncology Adjuvants Sales by Application (2021-2026) & (K Units) Table 55. Global Oncology Adjuvants Sales Market Share in Volume by Application (2021-2026) Table 56. Global Oncology Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 57. Global Oncology Adjuvants Sales Market Share in Value by Application (2021-2026) Table 58. Global Oncology Adjuvants Price by Application (2021-2026) & (US$/Unit) Table 59. Global Oncology Adjuvants Sales by Application (2027-2032) & (K Units) Table 60. Global Oncology Adjuvants Sales Market Share in Volume by Application (2027-2032) Table 61. Global Oncology Adjuvants Sales by Application (2027-2032) & (US$ Million) Table 62. Global Oncology Adjuvants Sales Market Share in Value by Application (2027-2032) Table 63. Global Oncology Adjuvants Price by Application (2027-2032) & (US$/Unit) Table 64. North America Oncology Adjuvants Sales by Application (2021-2026) & (K Units) Table 65. North America Oncology Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Oncology Adjuvants Sales by Application (2021-2026) & (K Units) Table 67. Europe Oncology Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Oncology Adjuvants Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Oncology Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Oncology Adjuvants Sales by Application (2021-2026) & (K Units) Table 71. Latin America Oncology Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Oncology Adjuvants Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Oncology Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 74. Zhendong Pharmaceutical Company Information Table 75. Zhendong Pharmaceutical Business Overview Table 76. Zhendong Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhendong Pharmaceutical Oncology Adjuvants Product Portfolio Table 78. Zhendong Pharmaceutical Recent Development Table 79. Yibai Pharmaceutical Company Information Table 80. Yibai Pharmaceutical Business Overview Table 81. Yibai Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Yibai Pharmaceutical Oncology Adjuvants Product Portfolio Table 83. Yibai Pharmaceutical Recent Development Table 84. Main Luck Pharmaceuticals Company Information Table 85. Main Luck Pharmaceuticals Business Overview Table 86. Main Luck Pharmaceuticals Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Main Luck Pharmaceuticals Oncology Adjuvants Product Portfolio Table 88. Main Luck Pharmaceuticals Recent Development Table 89. SL Pharmaceutical Company Information Table 90. SL Pharmaceutical Business Overview Table 91. SL Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. SL Pharmaceutical Oncology Adjuvants Product Portfolio Table 93. SL Pharmaceutical Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sanofi Oncology Adjuvants Product Portfolio Table 98. Sanofi Recent Development Table 99. Livzon Pharmaceutical Company Information Table 100. Livzon Pharmaceutical Business Overview Table 101. Livzon Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Livzon Pharmaceutical Oncology Adjuvants Product Portfolio Table 103. Livzon Pharmaceutical Recent Development Table 104. Eli Lilly Company Information Table 105. Eli Lilly Business Overview Table 106. Eli Lilly Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Eli Lilly Oncology Adjuvants Product Portfolio Table 108. Eli Lilly Recent Development Table 109. Pfizer Company Information Table 110. Pfizer Business Overview Table 111. Pfizer Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Pfizer Oncology Adjuvants Product Portfolio Table 113. Pfizer Recent Development Table 114. Sanjiu Medical Company Information Table 115. Sanjiu Medical Business Overview Table 116. Sanjiu Medical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sanjiu Medical Oncology Adjuvants Product Portfolio Table 118. Sanjiu Medical Recent Development Table 119. Hengrui Medicine Company Information Table 120. Hengrui Medicine Business Overview Table 121. Hengrui Medicine Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hengrui Medicine Oncology Adjuvants Product Portfolio Table 123. Hengrui Medicine Recent Development Table 124. Hisun Pharmaceutical Company Information Table 125. Hisun Pharmaceutical Business Overview Table 126. Hisun Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Hisun Pharmaceutical Oncology Adjuvants Product Portfolio Table 128. Hisun Pharmaceutical Recent Development Table 129. Biogen Company Information Table 130. Biogen Business Overview Table 131. Biogen Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Biogen Oncology Adjuvants Product Portfolio Table 133. Biogen Recent Development Table 134. Amgen Company Information Table 135. Amgen Business Overview Table 136. Amgen Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Amgen Oncology Adjuvants Product Portfolio Table 138. Amgen Recent Development Table 139. AstraZeneca Company Information Table 140. AstraZeneca Business Overview Table 141. AstraZeneca Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. AstraZeneca Oncology Adjuvants Product Portfolio Table 143. AstraZeneca Recent Development Table 144. BMS Company Information Table 145. BMS Business Overview Table 146. BMS Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. BMS Oncology Adjuvants Product Portfolio Table 148. BMS Recent Development Table 149. North America Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. North America Oncology Adjuvants Sales by Country (2021-2026) & (K Units) Table 151. North America Oncology Adjuvants Sales Market Share by Country (2021-2026) Table 152. North America Oncology Adjuvants Sales Forecast by Country (2027-2032) & (K Units) Table 153. North America Oncology Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 154. North America Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America Oncology Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 156. North America Oncology Adjuvants Market Share by Country (2021-2026) Table 157. North America Oncology Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America Oncology Adjuvants Market Share Forecast by Country (2027-2032) Table 159. Europe Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Europe Oncology Adjuvants Sales by Country (2021-2026) & (K Units) Table 161. Europe Oncology Adjuvants Sales Market Share by Country (2021-2026) Table 162. Europe Oncology Adjuvants Sales Forecast by Country (2027-2032) & (K Units) Table 163. Europe Oncology Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 164. Europe Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe Oncology Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe Oncology Adjuvants Market Share by Country (2021-2026) Table 167. Europe Oncology Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe Oncology Adjuvants Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Oncology Adjuvants Sales by Country (2021-2026) & (K Units) Table 171. Asia-Pacific Oncology Adjuvants Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific Oncology Adjuvants Sales Forecast by Country (2027-2032) & (K Units) Table 173. Asia-Pacific Oncology Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Oncology Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific Oncology Adjuvants Market Share by Country (2021-2026) Table 177. Asia-Pacific Oncology Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific Oncology Adjuvants Market Share Forecast by Country (2027-2032) Table 179. Latin America Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Latin America Oncology Adjuvants Sales by Country (2021-2026) & (K Units) Table 181. Latin America Oncology Adjuvants Sales Market Share by Country (2021-2026) Table 182. Latin America Oncology Adjuvants Sales Forecast by Country (2027-2032) & (K Units) Table 183. Latin America Oncology Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America Oncology Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America Oncology Adjuvants Market Share by Country (2021-2026) Table 187. Latin America Oncology Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America Oncology Adjuvants Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Oncology Adjuvants Sales by Country (2021-2026) & (K Units) Table 191. Middle East and Africa Oncology Adjuvants Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa Oncology Adjuvants Sales Forecast by Country (2027-2032) & (K Units) Table 193. Middle East and Africa Oncology Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Oncology Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Oncology Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Oncology Adjuvants Market Share by Country (2021-2026) Table 197. Middle East and Africa Oncology Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa Oncology Adjuvants Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Oncology Adjuvants Distributors List Table 202. Oncology Adjuvants Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Oncology Adjuvants Image Figure 2. Global Oncology Adjuvants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology Adjuvants Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology Adjuvants Sales (2021-2032) & (K Units) Figure 5. Immunotherapy Image Figure 6. Global Immunotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Hormone therapy Image Figure 8. Global Hormone therapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Chemotherapy Image Figure 10. Global Chemotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 11. Radiotherapy Image Figure 12. Global Radiotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 13. Targeted therapy Image Figure 14. Global Targeted therapy Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Oncology Adjuvants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Oncology Adjuvants Market Share by Type 2025 VS 2032 Figure 17. North America Oncology Adjuvants Sales Market Share in Volume by Type in 2025 Figure 18. North America Oncology Adjuvants Sales Market Share in Value by Type in 2025 Figure 19. Europe Oncology Adjuvants Sales Market Share in Volume by Type in 2025 Figure 20. Europe Oncology Adjuvants Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Oncology Adjuvants Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Oncology Adjuvants Sales Market Share in Value by Type in 2025 Figure 23. Latin America Oncology Adjuvants Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Oncology Adjuvants Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Oncology Adjuvants Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Oncology Adjuvants Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Oncology Adjuvants Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Cancer Research Institutes Image Figure 30. Global Cancer Research Institutes Sales YoY Growth (2021-2032) & (K Units) Figure 31. Cancer Hospitals Image Figure 32. Global Cancer Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Oncology Adjuvants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Oncology Adjuvants Market Share by Application 2025 VS 2032 Figure 35. North America Oncology Adjuvants Sales Market Share in Volume by Application in 2025 Figure 36. North America Oncology Adjuvants Sales Market Share in Value by Application in 2025 Figure 37. Europe Oncology Adjuvants Sales Market Share in Volume by Application in 2025 Figure 38. Europe Oncology Adjuvants Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Oncology Adjuvants Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Oncology Adjuvants Sales Market Share in Value by Application in 2025 Figure 41. Latin America Oncology Adjuvants Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Oncology Adjuvants Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Oncology Adjuvants Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Oncology Adjuvants Sales Market Share in Value by Application in 2025 Figure 45. North America Oncology Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Oncology Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Oncology Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Oncology Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oncology Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Oncology Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oncology Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Oncology Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oncology Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Oncology Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oncology Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Oncology Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oncology Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Oncology Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oncology Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Oncology Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oncology Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Oncology Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oncology Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Oncology Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oncology Adjuvants Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Oncology Adjuvants Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapy
  • Hormone therapy
  • Chemotherapy
  • Radiotherapy
  • Targeted therapy
Applications
  • Cancer Research Institutes
  • Cancer Hospitals
Companies covered
  • Zhendong Pharmaceutical
  • Yibai Pharmaceutical
  • Main Luck Pharmaceuticals
  • SL Pharmaceutical
  • Sanofi
  • Livzon Pharmaceutical
  • Eli Lilly
  • Pfizer
  • Sanjiu Medical
  • Hengrui Medicine
  • Hisun Pharmaceutical
  • Biogen
  • Amgen
  • AstraZeneca
  • BMS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oncology Adjuvants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oncology Adjuvants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oncology Adjuvants Market by Type
  6. 1.3.1 Immunotherapy
  7. 1.3.2 Hormone therapy
  8. 1.3.3 Chemotherapy
  9. 1.3.4 Radiotherapy
  10. 1.3.5 Targeted therapy
  11. 1.4 Global Oncology Adjuvants Market Size by Type
  12. 1.4.1 Global Oncology Adjuvants Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Oncology Adjuvants Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Oncology Adjuvants Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Oncology Adjuvants Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Oncology Adjuvants Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Oncology Adjuvants Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Oncology Adjuvants Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Oncology Adjuvants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oncology Adjuvants Industry Trends
  2. 2.2 Oncology Adjuvants Industry Drivers
  3. 2.3 Oncology Adjuvants Industry Opportunities and Challenges
  4. 2.4 Oncology Adjuvants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oncology Adjuvants Revenue (2021-2026)
  2. 3.2 Global Top Players by Oncology Adjuvants Sales (2021-2026)
  3. 3.3 Global Top Players by Oncology Adjuvants Price (2021-2026)
  4. 3.4 Global Oncology Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology Adjuvants Major Company Production Sites & Headquarters
  6. 3.6 Global Oncology Adjuvants Company, Product Type & Application
  7. 3.7 Global Oncology Adjuvants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology Adjuvants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology Adjuvants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology Adjuvants Tier 1, Tier 2, and Tier 3
4 Oncology Adjuvants Regional Status and Outlook
  1. 4.1 Global Oncology Adjuvants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oncology Adjuvants Historic Market Size by Region
  3. 4.2.1 Global Oncology Adjuvants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oncology Adjuvants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oncology Adjuvants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oncology Adjuvants Forecasted Market Size by Region
  7. 4.3.1 Global Oncology Adjuvants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oncology Adjuvants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oncology Adjuvants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oncology Adjuvants by Application
  1. 5.1 Oncology Adjuvants Market by Application
  2. 5.1.1 Cancer Research Institutes
  3. 5.1.2 Cancer Hospitals
  4. 5.2 Global Oncology Adjuvants Market Size by Application
  5. 5.2.1 Global Oncology Adjuvants Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oncology Adjuvants Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oncology Adjuvants Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oncology Adjuvants Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oncology Adjuvants Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oncology Adjuvants Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oncology Adjuvants Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oncology Adjuvants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhendong Pharmaceutical
  2. 6.1.1 Zhendong Pharmaceutical Company Information
  3. 6.1.2 Zhendong Pharmaceutical Business Overview
  4. 6.1.3 Zhendong Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhendong Pharmaceutical Oncology Adjuvants Product Portfolio
  6. 6.1.5 Zhendong Pharmaceutical Recent Developments
  7. 6.2 Yibai Pharmaceutical
  8. 6.2.1 Yibai Pharmaceutical Company Information
  9. 6.2.2 Yibai Pharmaceutical Business Overview
  10. 6.2.3 Yibai Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yibai Pharmaceutical Oncology Adjuvants Product Portfolio
  12. 6.2.5 Yibai Pharmaceutical Recent Developments
  13. 6.3 Main Luck Pharmaceuticals
  14. 6.3.1 Main Luck Pharmaceuticals Company Information
  15. 6.3.2 Main Luck Pharmaceuticals Business Overview
  16. 6.3.3 Main Luck Pharmaceuticals Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Main Luck Pharmaceuticals Oncology Adjuvants Product Portfolio
  18. 6.3.5 Main Luck Pharmaceuticals Recent Developments
  19. 6.4 SL Pharmaceutical
  20. 6.4.1 SL Pharmaceutical Company Information
  21. 6.4.2 SL Pharmaceutical Business Overview
  22. 6.4.3 SL Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SL Pharmaceutical Oncology Adjuvants Product Portfolio
  24. 6.4.5 SL Pharmaceutical Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Oncology Adjuvants Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Livzon Pharmaceutical
  32. 6.6.1 Livzon Pharmaceutical Company Information
  33. 6.6.2 Livzon Pharmaceutical Business Overview
  34. 6.6.3 Livzon Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Livzon Pharmaceutical Oncology Adjuvants Product Portfolio
  36. 6.6.5 Livzon Pharmaceutical Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Oncology Adjuvants Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Oncology Adjuvants Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Sanjiu Medical
  50. 6.9.1 Sanjiu Medical Company Information
  51. 6.9.2 Sanjiu Medical Business Overview
  52. 6.9.3 Sanjiu Medical Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanjiu Medical Oncology Adjuvants Product Portfolio
  54. 6.9.5 Sanjiu Medical Recent Developments
  55. 6.10 Hengrui Medicine
  56. 6.10.1 Hengrui Medicine Company Information
  57. 6.10.2 Hengrui Medicine Business Overview
  58. 6.10.3 Hengrui Medicine Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hengrui Medicine Oncology Adjuvants Product Portfolio
  60. 6.10.5 Hengrui Medicine Recent Developments
  61. 6.11 Hisun Pharmaceutical
  62. 6.11.1 Hisun Pharmaceutical Company Information
  63. 6.11.2 Hisun Pharmaceutical Business Overview
  64. 6.11.3 Hisun Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hisun Pharmaceutical Oncology Adjuvants Product Portfolio
  66. 6.11.5 Hisun Pharmaceutical Recent Developments
  67. 6.12 Biogen
  68. 6.12.1 Biogen Company Information
  69. 6.12.2 Biogen Business Overview
  70. 6.12.3 Biogen Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Biogen Oncology Adjuvants Product Portfolio
  72. 6.12.5 Biogen Recent Developments
  73. 6.13 Amgen
  74. 6.13.1 Amgen Company Information
  75. 6.13.2 Amgen Business Overview
  76. 6.13.3 Amgen Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Amgen Oncology Adjuvants Product Portfolio
  78. 6.13.5 Amgen Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AstraZeneca Oncology Adjuvants Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 BMS
  86. 6.15.1 BMS Company Information
  87. 6.15.2 BMS Business Overview
  88. 6.15.3 BMS Oncology Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 BMS Oncology Adjuvants Product Portfolio
  90. 6.15.5 BMS Recent Developments
7 North America by Country
  1. 7.1 North America Oncology Adjuvants Sales by Country
  2. 7.1.1 North America Oncology Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oncology Adjuvants Sales by Country (2021-2026)
  4. 7.1.3 North America Oncology Adjuvants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oncology Adjuvants Market Size by Country
  6. 7.2.1 North America Oncology Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oncology Adjuvants Market Size by Country (2021-2026)
  8. 7.2.3 North America Oncology Adjuvants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oncology Adjuvants Sales by Country
  2. 8.1.1 Europe Oncology Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oncology Adjuvants Sales by Country (2021-2026)
  4. 8.1.3 Europe Oncology Adjuvants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oncology Adjuvants Market Size by Country
  6. 8.2.1 Europe Oncology Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oncology Adjuvants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oncology Adjuvants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oncology Adjuvants Sales by Country
  2. 9.1.1 Asia-Pacific Oncology Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oncology Adjuvants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oncology Adjuvants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oncology Adjuvants Market Size by Country
  6. 9.2.1 Asia-Pacific Oncology Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oncology Adjuvants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oncology Adjuvants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oncology Adjuvants Sales by Country
  2. 10.1.1 South America Oncology Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oncology Adjuvants Sales by Country (2021-2026)
  4. 10.1.3 South America Oncology Adjuvants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oncology Adjuvants Market Size by Country
  6. 10.2.1 South America Oncology Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oncology Adjuvants Market Size by Country (2021-2026)
  8. 10.2.3 South America Oncology Adjuvants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oncology Adjuvants Sales by Country
  2. 11.1.1 Middle East and Africa Oncology Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oncology Adjuvants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oncology Adjuvants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oncology Adjuvants Market Size by Country
  6. 11.2.1 Middle East and Africa Oncology Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oncology Adjuvants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oncology Adjuvants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oncology Adjuvants Value Chain Analysis
  2. 12.1.1 Oncology Adjuvants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oncology Adjuvants Production Mode & Process
  7. 12.2 Oncology Adjuvants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oncology Adjuvants Distributors
  10. 12.2.3 Oncology Adjuvants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst